PRC1 promotes GLI1-dependent osteopontin expression in association with the Wnt/β-catenin signaling pathway and aggravates liver fibrosis.

GLI HSC Liver fibrosis Osteopontin PRC1 Wnt/β-catenin

Journal

Cell & bioscience
ISSN: 2045-3701
Titre abrégé: Cell Biosci
Pays: England
ID NLM: 101561195

Informations de publication

Date de publication:
2019
Historique:
received: 25 08 2019
accepted: 09 12 2019
entrez: 24 12 2019
pubmed: 24 12 2019
medline: 24 12 2019
Statut: epublish

Résumé

PRC1 (Protein regulator of cytokinesis 1) regulates microtubules organization and functions as a novel regulator in Wnt/β-catenin signaling pathway. Wnt/β-catenin is involved in development of liver fibrosis (LF). We aim to investigate effect and mechanism of PRC1 on liver fibrosis. Carbon tetrachloride (CCl PRC1 was up-regulated in CCl PRC1 aggravated LF through regulating Wnt/β-catenin mediated GLI1-dependent osteopontin expression, providing a new potential therapeutic target for LF treatment.

Sections du résumé

BACKGROUND BACKGROUND
PRC1 (Protein regulator of cytokinesis 1) regulates microtubules organization and functions as a novel regulator in Wnt/β-catenin signaling pathway. Wnt/β-catenin is involved in development of liver fibrosis (LF). We aim to investigate effect and mechanism of PRC1 on liver fibrosis.
METHODS METHODS
Carbon tetrachloride (CCl
RESULTS RESULTS
PRC1 was up-regulated in CCl
CONCLUSIONS CONCLUSIONS
PRC1 aggravated LF through regulating Wnt/β-catenin mediated GLI1-dependent osteopontin expression, providing a new potential therapeutic target for LF treatment.

Identifiants

pubmed: 31867100
doi: 10.1186/s13578-019-0363-2
pii: 363
pmc: PMC6916466
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100

Informations de copyright

© The Author(s) 2019.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests, and all authors should confirm its accuracy.

Références

Alcohol Clin Exp Res. 2011 May;35(5):787-93
pubmed: 21284667
Cell Death Dis. 2018 May 10;9(5):534
pubmed: 29748662
Gastroenterol Res Pract. 2015;2015:906026
pubmed: 26236336
Gastroenterology. 2015 Jun;148(7):1294-310
pubmed: 25747274
Gastroenterology. 2012 Nov;143(5):1319-1329.e11
pubmed: 22885334
Mol Med Rep. 2014 Jun;9(6):2145-51
pubmed: 24691643
Planta. 2009 Nov;230(6):1129-40
pubmed: 19756725
Cell Cycle. 2016 Jul 2;15(13):1667-73
pubmed: 27267766
Mol Med Rep. 2016 Oct;14(4):3669-75
pubmed: 27572112
Am J Physiol Lung Cell Mol Physiol. 2013 Sep 15;305(6):L419-31
pubmed: 23873844
Hepatology. 2012 Jul;56(1):389-91
pubmed: 22876366
Exp Mol Med. 2019 Jan 11;51(1):6
pubmed: 30635551
Oncotarget. 2015 Mar 30;6(9):7325-38
pubmed: 25356754
Pharmacol Ther. 2016 Oct;166:1-8
pubmed: 27343756
Sci Rep. 2016 Jun 08;6:27775
pubmed: 27270990
J Thorac Dis. 2017 Jul;9(7):2054-2060
pubmed: 28840006
Chem Biol Interact. 2011 Sep 30;193(3):225-31
pubmed: 21803030
J Biol Chem. 2009 Aug 21;284(34):22888-97
pubmed: 19556240
Cell Death Dis. 2018 May 29;9(6):639
pubmed: 29844390
Cell Death Dis. 2018 May 11;9(5):564
pubmed: 29752448
Lab Invest. 2013 Oct;93(10):1082-9
pubmed: 23999249
Med Sci Monit. 2018 Nov 06;24:7965-7974
pubmed: 30399613
Germs. 2019 Jun 03;9(2):102-105
pubmed: 31341838
EMBO Mol Med. 2015 Feb 13;7(3):332-8
pubmed: 25680861
Biochem Biophys Res Commun. 2019 Jan 8;508(2):543-549
pubmed: 30509494
Hum Mol Genet. 2011 Aug 15;20(16):3176-87
pubmed: 21593220
Pharmacol Res. 2019 Apr;142:251-261
pubmed: 30826456
Front Immunol. 2017 Nov 06;8:1450
pubmed: 29163520
J Hepatol. 2013 Nov;59(5):992-8
pubmed: 23838178
Cell Death Dis. 2018 Jun 18;9(7):718
pubmed: 29915227
J Hepatol. 2009 Dec;51(6):991-9
pubmed: 19853952
Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):167-77
pubmed: 21476912
Oncol Rep. 2006 Jul;16(1):91-6
pubmed: 16786128
Physiol Res. 2012;61(4):337-46
pubmed: 22670697
Hepatology. 2011 Jan;53(1):106-15
pubmed: 20967826
Gut. 2016 Sep;65(9):1522-34
pubmed: 26941395
Dig Dis Sci. 2012 Nov;57(11):3017-25
pubmed: 22592631
World J Gastroenterol. 2014 Jun 21;20(23):7260-76
pubmed: 24966597
Nat Genet. 2008 Sep;40(9):1130-5
pubmed: 19165927
Acta Biochim Biophys Sin (Shanghai). 2014 Apr;46(4):291-8
pubmed: 24389643
Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G39-49
pubmed: 18006602
Cancer Sci. 2007 Feb;98(2):174-81
pubmed: 17233835
Exp Mol Med. 2019 Apr 16;51(4):44
pubmed: 30992425
Mol Aspects Med. 2019 Feb;65:2-15
pubmed: 29958900
Cancer Res. 2007 Apr 1;67(7):3276-85
pubmed: 17409436
Toxicol Lett. 2018 Jun 1;289:86-98
pubmed: 29535048
J Gastroenterol Hepatol. 2005 Jul;20(7):1109-14
pubmed: 15955222
J Cell Sci. 2008 Mar 15;121(Pt 6):737-46
pubmed: 18322270

Auteurs

Shenzong Rao (S)

1Department of Transfusion, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022 China.

Jie Xiang (J)

Department of Laboratory Medicine, Wuhan Medical Treatment Center, Wuhan City, 430023 Hubei Province China.

Jingsong Huang (J)

3Department of Transfusion, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, No. 2000 Xiangan Eastroad, Xiangan District, Xiamen, 361101 China.

Shangang Zhang (S)

4Department of Rehabilitation Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, No. 2000 Xiangan Eastroad, Xiangan District, Xiamen, 361101 China.

Min Zhang (M)

1Department of Transfusion, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022 China.

Haoran Sun (H)

1Department of Transfusion, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022 China.

Jian Li (J)

1Department of Transfusion, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022 China.

Classifications MeSH